Create Account | Sign In: Author or Forum

News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    



Category: Anesthesiology & Pain | Monthly Briefing

Back to Journal Articles

October 2010 Briefing - Pain Management

Last Updated: November 01, 2010.


Share |

Comments: (0)




Here are what the editors at HealthDay consider to be the most important developments in Pain Management for October 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

FDA: Methotrexate Injection Vials Recalled

FRIDAY, Oct. 29 (HealthDay News) -- The U.S. Food and Drug Administration and Sandoz have notified health care professionals of a voluntary recall of 24 lots of methotrexate injection (50 mg/2 mL and 250 mg/10 mL vials) due to the presence of small glass particulates in a limited number of vials in four lots.

More Information

Opioid Substitution Rx Lowers Mortality Risk for Abusers

WEDNESDAY, Oct. 27 (HealthDay News) -- Despite increased risk during the first two weeks, the risk of death during opioid substitution therapy is lower, overall, than the risk of death out of treatment, according to research published online Oct. 26 in BMJ.

Full Text

Primary Care Trails Other Specialties in Hourly Wages

TUESDAY, Oct. 26 (HealthDay News) -- Primary care physicians have substantially lower hourly wages than other specialists, and although most physicians find Medicare reimbursement inequitable, they show little consensus on how to reform it, according to two studies published in the Oct. 25 issue of the Archives of Internal Medicine.

Abstract - Leigh
Full Text (subscription or payment may be required)
Abstract - Federman
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

FDA: Fentanyl Transdermal System Patches Recalled

MONDAY, Oct. 25 (HealthDay News) -- The U.S. Food and Drug Administration has notified health care professionals and patients that 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches (Duragesic) are being voluntarily recalled. The recall was issued due to the potential for the active ingredient, fentanyl, to release faster than indicated, which can lead to adverse events among at-risk patients, including excessive sedation, respiratory depression, hypoventilation, and apnea.

More Information

FDA Approves Botox for Chronic Migraine Treatment

MONDAY, Oct. 18 (HealthDay News) -- On Friday, Oct. 15, 2010, the U.S. Food and Drug Administration announced the approval of onabotulinumtoxinA (Botox) injection for the prevention of headaches in adult patients with chronic migraines.

More Information

New Love May Reduce Pain

FRIDAY, Oct. 15 (HealthDay News) -- Researchers testing newly in love undergraduates found that the activation of reward systems that occurred when the subjects viewed pictures of their loved one helped reduce pain during an experiment; their research was published online Oct. 13 in PLoS ONE.

Full Text

Expectations Don't Predict Recovery Time for All Injuries

FRIDAY, Oct. 15 (HealthDay News) -- Recovery expectations appear to predict future recovery among workers filing injury claims for back pain but not for those filing claims for other musculoskeletal conditions, according to a study published in the October issue of the Journal of Spinal Disorders & Techniques.

Full Text (subscription or payment may be required)

Fibromyalgia Sufferers May Benefit From Yoga Practice

THURSDAY, Oct. 14 (HealthDay News) -- Yoga might provide an effective counterpart to pharmacotherapy in helping patients cope with and manage fibromyalgia, according to research published in the November issue of Pain.

Full Text (subscription or payment may be required)

Vivitrol Approved to Prevent Opioid Addiction Relapse

WEDNESDAY, Oct. 13 (HealthDay News) -- Vivitrol (naltrexone extended release) has been approved by the U.S. Food and Drug Administration to treat and prevent relapse among opioid-dependent people who have completed a detoxification program.

drug abuse

Buprenorphine Implants Effective in Opioid Dependence

TUESDAY, Oct. 12 (HealthDay News) -- Implanted buprenorphine is an effective alternative for treatment of opioid dependency, resulting in fewer withdrawal symptoms and less treatment drop-out than placebo implants, according to research published in the Oct. 13 issue of The Journal of the American Medical Association.

Full Text (subscription or payment may be required)

Older Women at Fracture Risk in Spinal Instrumentation Surgery

TUESDAY, Oct. 12 (HealthDay News) -- Postmenopausal women who have spinal fusion with instrumentation are at risk of developing fractures at other nearby vertebrae, usually within two years of the surgery, according to a study in the Oct. 1 issue of Spine.

Full Text (subscription or payment may be required)

Somatic Symptom Burden High in Cancer Patients

TUESDAY, Oct. 12 (HealthDay News) -- Regardless of cancer type or phase, there is a high prevalence of somatic symptoms in cancer patients with chronic pain or depression, according to research published Oct. 11 in the Archives of Internal Medicine.

Full Text (subscription or payment may be required)

Remembered Back Injury Not Predictor for Disc Deterioration

TUESDAY, Oct. 12 (HealthDay News) -- Recollection of a previous back injury does not predict accelerated deterioration of spinal discs, according to a study among identical twins with and without reported prior back injuries, which was published in the Oct. 1 issue of Spine.

Full Text (subscription or payment may be required)

Word Choice Influences Patient Perception of Prognosis

MONDAY, Oct. 11 (HealthDay News) -- The way clinicians explain a patient's back pain may influence the patient's perceived prognosis and uptake of therapy; sticking with language used in radiology reports may be more helpful than using degenerative terms, such as "wear and tear," according to research published in the Oct. 1 issue of Spine.

Full Text (subscription or payment may be required)

Arthritis Prevalence Nearly 25 Percent in U.S. Adults

FRIDAY, Oct. 8 (HealthDay News) -- Nearly a quarter of U.S. adults have doctor-diagnosed arthritis and many also have arthritis-attributable activity limitation (AAAL); the prevalence of arthritis is particularly high among obese individuals, according to a report published in the Oct. 8 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Full Text

Abatacept Found Ineffective for Non-Life-Threatening Lupus

THURSDAY, Oct. 7 (HealthDay News) -- In patients with non-life-threatening systemic lupus erythematosus (SLE), abatacept fails to prevent new flares and has a nearly one-in-five rate of serious adverse events (SAEs), according to a study in the October issue of Arthritis & Rheumatism.

Full Text (subscription or payment may be required)

No Single Standard for Faces Pain Scales for Children

MONDAY, Oct. 4 (HealthDay News) -- There is no single faces pain scale for use in children that is superior to the others in all respects, according to an article published online Oct. 4 in Pediatrics.

Full Text (subscription or payment may be required)

DMARDs, Glucocorticoids, Biologics Similar for RA

FRIDAY, Oct. 1 (HealthDay News) -- Treatment of rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs (DMARDs), glucocorticoids, biologics, or a combination of these agents significantly reduces radiographic evidence of joint destruction, with no advantage seen for patients whose treatment includes biologics, according to research published in the October issue of Arthritis & Rheumatism.

Full Text (subscription or payment may be required)

FDA Calls for Halt on Marketing of Unapproved Colchicine

FRIDAY, Oct. 1 (HealthDay News) -- The U.S. Food and Drug Administration has ordered companies manufacturing, distributing, or marketing unapproved single-ingredient oral colchicine to cease doing so.

More Information

Copyright © 2010 ScoutNews, LLC. All rights reserved.

Previous: October 2010 Briefing - Geriatrics Next: October 2010 Briefing - Pharmacy

Reader comments on this article are listed below. Review our comments policy.

Submit your opinion:





Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application


 advertisement.gif (61x7 -- 0 bytes)



Useful Sites
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.